BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10528788)

  • 1. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
    Whitby M
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S67-71. PubMed ID: 10528788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.
    Chang SC; Hsieh SM; Chen ML; Sheng WH; Chen YC
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):131-6. PubMed ID: 10705056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
    Howden BP; Grayson ML
    Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
    Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
    Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 6. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Leclercq R; Duval J; Carbon C
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
    Downey DG; Kidd TJ; Coulter C; Bell SC
    J Cyst Fibros; 2005 Sep; 4(3):205-7. PubMed ID: 16019268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Staphylococcus aureus to fusidic acid: Canadian data.
    Rennie RP
    J Cutan Med Surg; 2006; 10(6):277-80. PubMed ID: 17241597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusidic acid resistance in Staphylococcus aureus.
    Dobie D; Gray J
    Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusidic acid in bone and joint infections.
    Atkins B; Gottlieb T
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mupirocin-resistant methicillin-resistant Staphylococcus aureus.
    Ambler JE; Drabu YJ
    J Hosp Infect; 1996 Jan; 32(1):71-82. PubMed ID: 8904376
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
    Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
    Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
    Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
    Alreshidi MA; Mariana NS
    Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
    [No Abstract]   [Full Text] [Related]  

  • 16. Fusidic acid in septicaemia and endocarditis.
    Whitby M
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S17-22. PubMed ID: 10528783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
    Aubin GG; Bémer P; Guillouzouic A; Launay E; Geffroy L; Touchais S; Corvec S
    Infect Dis (Lond); 2016 Sep; 48(9):699-702. PubMed ID: 27194514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fatal infection caused by methicillin-resistant Staphylococcus aureus acquiring resistance to gentamicin and fusidic acid during therapy.
    Amirak ID; Li AK; Williams RJ; Noone P
    J Infect; 1981 Mar; 3(1):50-8. PubMed ID: 6926536
    [No Abstract]   [Full Text] [Related]  

  • 19. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study.
    Mason BW; Howard AJ
    Int J Antimicrob Agents; 2004 Mar; 23(3):300-3. PubMed ID: 15164973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal bacteraemia and endocarditis and fusidic acid.
    Eykyn SJ
    J Antimicrob Chemother; 1990 Feb; 25 Suppl B():33-8. PubMed ID: 2312444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.